Health Coaching, Continuous Glucose Monitoring and AI Mobile App in Diabetes
Continuous Assessment of Risk and Efficacy (CARE) Using Health Coaching, Continuous Glucose Monitoring and AI Mobile App in Diabetes
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Lian Leng Low
- Phone Number: 63265872
- Email: low.lian.leng@singhealth.com.sg
Study Locations
-
-
-
Singapore, Singapore
- Recruiting
- National Heart Centre Singapore
-
Contact:
- Weiting Huang
- Email: huang.weiting@singhealth.com.sg
-
Singapore, Singapore
- Recruiting
- Sengkang General Hospital
-
Contact:
- Sueziani Binte Zainudin
- Email: sueziani.zainudin@singhealth.com.sg
-
Singapore, Singapore, 486838
- Recruiting
- Singapore General Hospital
-
Contact:
- Lian Leng Low
- Phone Number: 91051097
- Email: low.lian.leng@singhealth.com.sg
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Aged 21 years and above
- Have diagnosis of type 2 diabetes mellitus
- Provided informed consent
- Have near-field communication (NFC) compatible phones
- Able to engage in light physical activity (e.g., walking)
Exclusion Criteria:
- Significant cognitive impairment
- Other conditions that may preclude participants from wearing CGM devices
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Intervention
|
Each CGM device will work for 14 days. The participants will use the CGM devices for the first two-week period in the first three months of the trial, and the first two-week period of the second three months of the trial. Participants will interact with health coach throughout the study duration.
Nudges will be delivered through the EMPOWER mobile app.
Participants will log lifestyle information such as diet and physical activity, and clinical information such as medication and HbA1c levels through the EMPOWER mobile app.
|
|
Other: Control
|
Nudges will be delivered through the EMPOWER mobile app.
Participants will log lifestyle information such as diet and physical activity, and clinical information such as medication and HbA1c levels through the EMPOWER mobile app.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
HbA1c
Time Frame: 6 months
|
HbA1c over 6 months
|
6 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Physical activity as measured by number of steps
Time Frame: 6 months
|
Physical activity over 6 months
|
6 months
|
|
Physical activity as measured by moderate to vigorous active minutes
Time Frame: 6 months
|
Physical activity over 6 months
|
6 months
|
|
Physical activity as measured by GPAQ
Time Frame: 6 months
|
Physical activity over 6 months
|
6 months
|
|
Diet as measured by DASH
Time Frame: 6 months
|
Diet quality over 6 months
|
6 months
|
|
Sugar sweetened beverages intake
Time Frame: 6 months
|
Sugar sweetened beverages intake over 6 months
|
6 months
|
|
Patient activation score as measured by patient activation measure
Time Frame: 6 months
|
Difference in patient activation score between intervention and control over 6 months
|
6 months
|
|
Medication adherence as measured by DOSE-Nonadherence scale
Time Frame: 6 months
|
Difference in medication adherence between intervention and control over 6 months
|
6 months
|
|
Quality of life as measured by EQ-5D-5L
Time Frame: 6 months
|
Difference in quality of life between intervention and control over 6 months
|
6 months
|
|
Healthcare cost as measured by cost of consultations, lab tests, medications, admission
Time Frame: 6 months
|
Healthcare cost over 6 months
|
6 months
|
|
Healthcare cost as measured by WPAI
Time Frame: 6 months
|
Healthcare cost over 6 months
|
6 months
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 202208-00017
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.